Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$26.32 - $34.31 $499,132 - $650,654
18,964 Added 17.49%
127,371 $4.3 Million
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $951 - $1,242
31 Added 0.03%
108,407 $3.33 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $47.5 $180 - $237
5 Added 0.0%
108,376 $4.34 Million
Q1 2023

May 15, 2023

BUY
$35.53 - $43.38 $629,733 - $768,867
17,724 Added 19.55%
108,371 $4.42 Million
Q4 2022

Feb 14, 2023

SELL
$38.19 - $57.45 $17,720 - $26,656
-464 Reduced 0.51%
90,647 $3.5 Million
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $168,015 - $193,100
3,279 Added 3.73%
91,111 $4.85 Million
Q2 2022

Aug 15, 2022

BUY
$51.49 - $81.64 $1,647 - $2,612
32 Added 0.04%
87,832 $5.12 Million
Q4 2021

Feb 14, 2022

BUY
$47.97 - $62.21 $4.21 Million - $5.46 Million
87,800 New
87,800 $5.28 Million
Q3 2020

Nov 16, 2020

SELL
$51.97 - $63.0 $10.4 Million - $12.6 Million
-200,720 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$30.8 - $52.47 $261,430 - $445,365
8,488 Added 4.42%
200,720 $10.5 Million
Q1 2020

May 15, 2020

SELL
$28.4 - $50.7 $5.66 Million - $10.1 Million
-199,236 Reduced 50.89%
192,232 $6.45 Million
Q4 2019

Feb 14, 2020

BUY
$36.31 - $46.83 $14.2 Million - $18.3 Million
391,468 New
391,468 $17.7 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.19B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.